Abbott India appoints Prithwish K Banerji as Commercial Director - Women’s Health, Metabolics and International Business
Prithwish has close to 28 years of experience in a Commercial role
Prithwish has close to 28 years of experience in a Commercial role
The company has reported total income of Rs. 1,693.15 crores during the period ended September 30, 2024
This license will enable Abbott to enhance access to this novel therapy to more patients across India
Offering testing, treatment and support to help stop the spread of HIV and other infectious diseases
Abbott's first-of-its-kind i2i technology enables synchronized communication between two leadless pacemakers
The company has posted net profit of Rs. 1,201.22 crores for the Financial Year ended March 31, 2024
TriClip offers a remarkably safe, minimally invasive treatment option for patients in need of tricuspid valve repair but who are unable to withstand surgery
Dalal is an experienced leader at Abbott, having joined in 1995 as a Product Manager
Abbott India has reported total income of Rs. 1492.75 crores during the period ended December 31, 2023
His resignation would be effective from March 18, 2024
Subscribe To Our Newsletter & Stay Updated